Piotr Giedziun & Michał Krasoń

CancerCenter.AI

Piotr Giedziun (CancerCenter.AI Co-founder, R&D) is a passionate software engineer with specialization in deep learning (DL), algorithmics, highly-scalable architectures and advanced mobile technologies. Piotr is an astute proponent of maximizing optimization in software developing processes. His focused specialization is in MRI diagnostics and skin lesion analysis. He is a practitioner of machine learning (ML) algorithms and beautifully clean code design.

Michał Krasoń is a data scientist with background in mathematics. He works in R&D department of CancerCenter.AI where he focuses on applications of deep learning to medical image analysis. His main interest is in computer vision and novel machine learning methods.

dont miss

Deep learning in oncology diagnostics

Medical diagnosis is a complex and time-consuming process. Facilitating it could bring us a number of benefits, e.g. increase the chances of early detection of cancer. During the seminar we will see how current state-of-the-art computer vision algorithms can be used to achieve this goal.

Piotr Giedziun & Michał Krasoń will be speaking in the following theatre:

Theatre 10 - Tuesday 14.45 - 15.15: Deep learning in oncology diagnostics

Theatre 9 - Tuesday 16.15 - 16.45: Deep learning in oncology diagnostics

EVEN MORE SEMINARS

  • Professor Sun Myint: Speaking at the Oncology Convention

    Professor Sun Myint
    Clatterbridge Cancer Centre (Private Clinic)

    Rectal cancer- Do patients have a choice?

  • Clare Hutton & Peter Colley: Speaking at the Oncology Convention

    Clare Hutton & Peter Colley
    Hull & East Yorkshire Hospitals NHS Trust

    The Implementation & Development of IMRT in Hull

  • DR Zayad Ratansi: Speaking at the Oncology Convention

    DR Zayad Ratansi
    o3 Health Ltd

    Hyperbarics within Oncology

  • Luca Boldrini: Speaking at the Oncology Convention

    Luca Boldrini
    Università Cattolica del Sacro Cuore, Roma, Italia

    Radiomics applications rectal cancer: the MRIdian perspective

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development